CO Academic Day

Saif is a CRUK funded academic consultant in clinical oncology based at the University of Cambridge. His research focuses on identifying mechanisms of radiation resistance through novel approaches such as CRISPR based screening methods, in 2D, 3D and in vivo models. He also treats breast cancer patients with radiotherapy and chemotherapy.

Hannah is a NIHR Academic Clinical Fellow and Specialist Trainee in Clinical Oncology in the North West Deanery. She has an interest in cancer related research and gained her PhD in Health Economics from the Universities of Melbourne and Birmingham, She is currently working toward an Academic Clinical Lectureship whilst completing her clinical training in Clinical Oncology.

Professor Choudhury is Chair and Honorary Consultant in Clinical Oncology. She joined The Christie in 2008 specialising in urology and sarcoma and has a strong interest in translational research. In 2013, she decided to focus on radiotherapy-related research in prostate and bladder cancers. Her current research aims to optimise and personalise radiotherapy using new techniques or imaging technology to deliver high doses of radiotherapy while minimising side-effects, and predictive biomarkers to determine which patients benefit from different treatments. Within the Division of Cancer Sciences, The University of Manchester, she is clinical lead for advanced radiotherapy, including the MRLinac project, and is co-Group Leader of The Translational Radiobiology Group.

Professor Choudhury graduated from Trinity College, Cambridge, but undertook her Clinical Oncology training at the Yorkshire Deanery from 2000-2008. Between 2005 and 2007, she was a Cancer Research UK Clinical Training Research Fellow and she undertook her PhD at the University of Leeds and Princess Margaret Hospital in Toronto, Canada. She has a lead role in education and training for specialist registrars and clinical fellows.

Over the past few years, Professor Choudhury has been involved with national concerns such as the Royal College of Radiologists, the National Cancer Research Institute (NCRI) Clinical and Translational Radiotherapy Research Working Group (CTRad), the NCRI Bladder Clinical Studies Group and the National Institute of Health and Care Excellence (NICE).  Professor Choudhury was Senior Editor for genito-urinary cancers for the International Journal of Radiation Oncology • Biology • Physics (The Red Journal). Since early 2021, she has been the Editor in Chief of Clinical Oncology.

I am a post-doctoral researcher with an interest in functional and molecular imaging. My research focuses on the biological validation of imaging biomarkers and developing them for radiotherapy trials.

Dr Harshani Green is a Locum Clinical Oncology Consultant at the Royal Marsden Hospital and MD fellow at the Institute of Cancer Research. Her MD focuses on optimising advanced radiotherapy techniques in kidney cancer.  Post-CCT she completed a Proton Beam Therapy Fellowship in London.  She has also collaborated internationally through an RCR/Cyclotron Trust visiting fellowship to Italy.  As co-chair of UK Early Career Researchers in Cancer, Harshani aims to champion novel collaborations and equal opportunities in cancer research.  She is very grateful for the unwavering support from her colleagues, family and patients during her research journey.  

Richard Grieve leads a research team who uses large scale NHS data to evaluate the effectiveness and cost-effectiveness of alternative health care interventions, including for early-stage cancers. Richard's work is mainly funded by NIHR and MRC. Richard advises NICE and the Department of Health and Social Care.

Emma Hall, Professor of Oncology Trials, is Co-Director of the Cancer Research UK-funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU), London, UK. She is a chartered statistician with over 25 years’ experience in the design, methodology and analysis of oncology clinical trials.  She leads the ICR-CTSU’s portfolio of research in genitourinary and head and neck cancers with focus on the design and analysis of radiotherapy clinical trials.  She is an honorary member of the Royal College of Radiologists and an affiliate member of the European Society for Radiation and Oncology (ESTRO).

Emma is an IMT1 working in London. She has a strong interest in clinical oncology and has undertaken an MRes in Biomedical Science and Translational Medicine alongside a PGCert in Medical Education (Oncology). 
Emma has conducted research within many areas including outcomes of patients with covid-19 and cancer, breast and gynaecological cancers as well as medication education. Emma is past Chair of the British Oncology Network for Undergraduate Societies (BONUS), is a member of The Royal College of Radiologists (RCR) Undergraduate Steering Committee as well an informal member of the RCR's Academic Committee.